GoodRx appoints Kelly J. Kennedy to Board of Directors, fills vacancy

GoodRx Holdings, Inc.

Kennedy elected as Class I director effective Dec 21, 2023; term expires at 2024 annual meeting.
She replaces Jacqueline Kosecoff and will serve on the Audit Committee.
Kennedy is former CFO of The Honest Company and Willow Innovations; over 25 years experience.
Received initial RSU award valued at $420,000, vesting over three years.
Board adopted Deferred Compensation Plan for non-employee directors, effective Jan 1, 2024.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kelly J. Kennedy

Director

GDRX · GoodRx Holdings, Inc.

Effective: 2023-12-21
Filed: December 22, 2023, 6:59 PM ET

On December 21, 2023, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, elected Kelly J. Kennedy as a Class I director, effective immediately, to fill an existing vacancy on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kelly J. Kennedy was elected as Director at GoodRx Holdings, Inc..

Action: elected
Role: Director

Exact text from the filing

On December 21, 2023, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, elected Kelly J. Kennedy as a Class I director, effective immediately, to fill an existing vacancy on the Board.

View on SEC.gov

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001809519-23-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.